John P. Saharek serves as Executive at Imprimis Pharmaceuticals, Inc., where they oversee executive responsibilities. Since joining the company, John P. Saharek has executed 13 insider transactions totaling $0, demonstrating a balanced approach to their equity position. Their most recent transaction on Sep 11, 2024 involved selling 45,140 shares valued at $1.9M.
John P. Saharek currently holds 299,663 shares of Imprimis Pharmaceuticals, Inc. (IMMY), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, John P. Saharek has been a net neutral trader of IMMY stock. They have purchased $0 and sold $0 worth of shares.
John P. Saharek's most recent insider trade was on Sep 11, 2024, when they sold 45,140 shares at $41.37 per share.
Get notified when new Form 4 filings are submitted
| 90,000 |
| $7.37 |
| Discretionary |
| Mar 1, 2024 | HROW | $43.8K | Option Exercise | 5,000 | $8.75 | Discretionary |
| Feb 20, 2024 | HROW | $320.1K | Option Exercise | 30,000 | $10.67 | Discretionary |
| Feb 20, 2024 | HROW | $134.6K | Option Exercise | 12,616 | $10.67 | Discretionary |
| Nov 10, 2023 | HROW | $125.5K | Payment | 9,778 | $12.83 | Discretionary |
| Nov 10, 2023 | HROW | $0 | Option Exercise | 20,000 | $N/A | Discretionary |
| Jul 18, 2023 | HROW | $2.0M | Payment | 109,080 | $18.23 | Discretionary |
| Jul 18, 2023 | HROW | $0 | Option Exercise | 277,200 | $N/A | Discretionary |
| Feb 19, 2022 | HROW | $204.0K | Payment | 25,923 | $7.87 | Discretionary |
| Feb 19, 2022 | HROW | $0 | Option Exercise | 50,000 | $N/A | Discretionary |
| Feb 1, 2018 | IMMY | $54.9K | Option Exercise | 30,000 | $1.83 | Discretionary |
| Feb 1, 2015 | IMMY | $0 | Award | 30,000 | $N/A | Discretionary |